MRI bone marrow findings in 63 patients with type i gaucher disease

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 182, Issue 11, 2010, Pages 979-985

  Poll, L W ^a   Willers, R ^b   Haussinger D ^c   Modder U ^c   Vom Dahl, S ^d  

^a BG Unfallklinik Duisburg GmbH   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

extremities; marrow; MR imaging

Indexed keywords

ADULT; AGED; ARTICLE; AVASCULAR NECROSIS; BONE MARROW DISEASE; CORRELATION ANALYSIS; EDEMA; FEMALE; FEMUR HEAD NECROSIS; GAUCHER DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCORING SYSTEM; BONE MARROW; EPIPHYSIS; FEMUR HEAD; IMAGE PROCESSING; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TIBIA;

ADULT; AGED; BONE MARROW; EPIPHYSES; FEMALE; FEMUR HEAD; FEMUR HEAD NECROSIS; GAUCHER DISEASE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TIBIA; YOUNG ADULT;

EID: 78049392583     PISSN: 14389029     EISSN: 14389010     Source Type: Journal    
DOI: 10.1055/s-0029-1245410     Document Type: Article

References (30)

1. Beutler E, Grabowski G A. Gaucher disease. In Scriver C R. Beaudet A L. Sly W S. eds The metabolic and molecular bases of inherited disease. 8th. ed New York, NY McGraw-Hill 2001 3635-3668
2. Weinreb N, Barranger J, Packman S et al. Imiglucerase (Cerezyme) improves quality of life in patients with skeletal manifestations of Gaucher disease. Clin Genet 2007 71 576-588
3. Stowens D W., Teitelbaum S L., Kahn A J. et al. Skeletal complications of Gaucher disease. Medicine 1985 64 310-322
4. Poll L W., Koch J A., Dahl S vom et al. Epigastrischer Gaucher-Zell-Pseudo-Tumor: Bildmorphologische und Histologische Charakteristika. Fortschr Röntgenstr 1998 169 669-672
5. Poll L W., Koch J A., Dahl S vom et al. Extraosseous manifestation of Gauchers disease type I: MR and histological appearance. Eur Radiol 2000 10 1660-1663
6. Poll L W., Koch J A., Dahl S vom et al. Type I Gaucher disease: extraosseous extension of skeletal disease. Skeletal Radiol 2000 29 15-21
7. Goldblatt J, Sacks S, Beighton P. The orthopedic aspects of Gaucher disease. Clin Orthop Relat Res 1978 137 208-214
8. Weinreb N J., Charrow J, Andersson H C. et al. Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry. Am J Med 2002 113 112-119
9. Poll L W., Koch J A., Willers R et al. Correlation of bone marrow response with hematological, biochemical, and visceral responses to enzyme replacement therapy of nonneuronopathic (type 1) Gaucher disease in 30 adult patients. Blood Cells Mol Dis 2002 28 209-220
10. Schmitz J, Poll L W., Dahl S vom. Therapy of adult Gaucher disease. Haematologica 2007 92 148-152
11. Pastores G M., Weinreb N J., Aerts H et al. Therapeutic goals in the treatment of Gaucher disease. Semin Hematol 2004 4 4-14
12. Weinreb N J., Aggio M C., Andersson H C. et al. International Collaborative Gaucher Group (ICGG). Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients. Semin Hematol 2004 41 15-22
13. Vom Dahl S, Poll L, Di Rocco M et al. Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients. Curr Med Res Opin 2006 22 1045-1064
14. Cox T M., Aerts J M., Belmatoug N et al. Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring. J Inherit Metab Dis 2008 31 319-336
15. Andersson H C., Charrow J, Kaplan P et al. International Collaborative Gaucher Group U. S. Regional Coordinators. Individualization of long-term enzyme replacement therapy for Gaucher disease. Genet Med 2005 7 105-110
16. Poll L W., Koch J A., Dahl S vom et al. Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results. Skeletal Radiol 2001 29 563-571
17. Poll L W., Maas M, Terk M R. et al. Response of Gaucher bone disease to enzyme replacement therapy. Br J Radiol 2002 75 A25-A36
18. Maas M, Hollak C E., Akkerman E M. et al. Quantification of skeletal involvement in adults with type I Gauchers disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter. Am J Roentgenol 2002 179 961-965
19. Gardeniers J WM. Report of the Committee of Staging and Nomenclature. ARCO 1993 5 79-82 News Letter
20. Hermann G, Shapiro R S., Abdelwahab I F. et al. MR imaging in adults with Gaucher disease type I: evaluation of marrow involvement and disease activity. Skeletal Radiol 1993 22 247-251
21. Rosenthal D I., Doppelt S H., Mankin H J. et al. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase. Pediatrics 1995 96 629-637
22. DeMayo R F., Haims A H., McRae M C. et al. Correlation of MRI-Based bone marrow burden score with genotype and spleen status in Gauchers disease. Am J Roentgenol 2008 191 115-123
23. Rosenthal D I., Scott J A., Barranger J et al. Evaluation of Gaucher disease using magnetic resonance imaging. J Bone Joint Surg Am 1986 68 802-808
24. Terk M R., Esplin J, Lee K et al. MR imaging of patients with type 1 Gauchers disease: relationship between bone and visceral changes. Am J Roentgenol 1995 165 599-604
25. Sims K B., Pastores G M., Weinreb N J. et al. Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study. Clin Genet 2008 73 430-440
26. Niederau C, Dahl S vom, Häussinger D. First long-term results of imiglucerase therapy of type 1 Gaucher disease. Eur J Med Res 1998 3 25-30
27. Fost M de, Hollak C E., Groener J E. et al. Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis. Blood 2006 108 830-835
28. Fost M de, Noesel C J., Aerts J M. et al. Persistent bone disease in adult type 1 Gaucher disease despite increasing doses of enzyme replacement therapy. Haematologica 2008 93 1119-1120
29. Grabowski G van, Kacena K, Hollak C E. et al. Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1. Genet Med 2009 11 92-100
30. Robertson P L., Maas M, Goldblatt J. Semiquantitative assessment of skeletal response to enzyme replacement therapy for Gauchers disease using the bone marrow burden score. Am J Roentgenol 2007 188 1521-1528